• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of methods to control growth of primary culture of human renal proximal tubular cells for the bio-artificial kidney device

Research Project

Project/Area Number 18590910
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionTokai University

Principal Investigator

SAWADA Kaichiro  Tokai University, School of Medicine, Researcher (10420952)

Co-Investigator(Kenkyū-buntansha) SAITO Akira  Tokai University, 医学部, Professor (60307296)
AUNG Tun  Tokai University, 医学部, Researcher (50398749)
Project Period (FY) 2006 – 2007
Project Status Completed (Fiscal Year 2007)
Budget Amount *help
¥4,010,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥510,000)
Fiscal Year 2007: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2006: ¥1,800,000 (Direct Cost: ¥1,800,000)
Keywordsbio-artificial kidney device / renal proximal tubul cells / the limit on cell division / and-sense technology / RNA interference / hollow-fiber modules / ヒト近位尿細管上皮細胞 / バイオ人工尿細管 / ヒト尿細管上皮細胞 / アンチセンスオリゴDNA / 細胞周期調節因子 / テロメラーゼ / 細胞株化
Research Abstract

To prepare enough amounts of cells for producing bio-artificial kidney devices, antisense technologies were applied to the primary culture of human renal proximal tubular cells (RPTECs). RPTECs become senescent after about 15 divisions in normal culture conditions. To expand the number of cell-division beyond the limit, antisense oligo-DNAs for genes of cell-cycle regulators (p53, RB, p16, p21) were applied to the culture medium at 10 micro-mole / L. As a result, the limit of cell-divisions was increased up to about 25 cycles. It means that about 1000 times of cells cultured in normal medium could be harvested. Furthermore, application of RNAi (RNA interference) for p53 or p16 genes made cells pass through 40 cycles of cell division. About 67 million times of normal cells would be expected to be harvested at the conditions. Cells beyond the normal limit of cell-divisions continued to express gamma-GTP that is a marker of RPTECs. Because these cells are free from virus and onco-genes, they are thought to be suitable for clinical applications. So, methods to control growth of primary culture of RPTECs were established and preparation of enough amounts of functional cells for the bio-artificial kidney device could be achieved. On the other hand, we inoculated human renal cells into hollow fibers in a dialysis module, and connected the module with a goat to evaluate its functions. Transport of water, glucose, and ions between inner and outer of hollows were measured. The circulation of blood was possible to be continued for two weeks. In conclusion, basic technologies for producing the bio-artificial kidney device with the primary culture of RPTECs, and for evaluating renal functions of the device by using model animals were established so far.

Report

(3 results)
  • 2007 Annual Research Report   Final Research Report Summary
  • 2006 Annual Research Report

URL: 

Published: 2006-04-01   Modified: 2021-04-07  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi